Commitments and Contingencies (Details) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Oct. 31, 2014 |
Jun. 30, 2015 |
Sep. 30, 2015 |
Dec. 31, 2014 |
|
| Business Acquisition [Line Items] | ||||
| Litigation Settlement, Amount | $ 3,000 | $ 2,800 | ||
| Business Combination, Indemnification Assets, Amount as of Acquisition Date | $ 2,500 | |||
| Payments for Legal Settlements | 300 | |||
| Settlement Liabilities, Current | 500 | $ 500 | ||
| Regulatory Liability, Noncurrent | 2,250 | 2,500 | ||
| Letters of Credit Outstanding, Amount | $ 1,100 | $ 1,400 | ||
| Common Stock, Par Value | $ 0.01 | $ 0.01 | ||
| RedPath Integrated Pathology, Inc [Member] | ||||
| Business Acquisition [Line Items] | ||||
| Adjustments to Additional Paid in Capital, Other | $ 6,100 | |||
| Business Acquisition, Equity Interest Issued or Issuable, Number of Shares | 500,000 | |||
| Stock Issued During Period, Value, Treasury Stock Reissued | $ 6,100 | |||
| Common Stock, Par Value | $ 0.0001 |
| X | ||||||||||
- Definition Amount of other increase (decrease) in additional paid in capital (APIC). No definition available.
|
| X | ||||||||||
- Definition Number of shares of equity interests issued or issuable to acquire entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The amount of indemnification assets (amounts to be reimbursed if and when certain assumed liabilities are paid) recognized at the acquisition date of a business combination. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The total amount of the contingent obligation under letters of credit outstanding as of the reporting date. No definition available.
|
| X | ||||||||||
- Definition Amount of judgment or settlement awarded to (against) the entity in respect of litigation. No definition available.
|
| X | ||||||||||
- Definition The amount of cash paid for the settlement of litigation or for other legal issues during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The amount for the individual regulatory noncurrent liability as itemized in a table of regulatory noncurrent liabilities as of the end of the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amounts payable for money transfers, money orders, and consumer payment service arrangements. Settlement liabilities include amounts payable to intermediaries for global payment transfers. No definition available.
|
| X | ||||||||||
- Definition Equity impact of the value of treasury stock (units) reissued during the period, excluding reissuance of shares (units) held in treasury used to satisfy equity-based compensation obligations exercised by the holders of such rights. Upon reissuance of shares (units) from treasury, either the common or preferred stock (unit) reissued is outstanding. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Details
|